K.I.S. Kelini, M.S.M. Saleh, M.A.M. Abbas, M.B.I. Bayoumi, S.M. Ahmed
Lasers in Medical Science, 40(1):123, 2025
The present study aimed to investigate the effects of high-intensity laser therapy and short-wave diathermy, both with exercise, on pain, physical function, and quality of life in patients with knee osteoarthritis and compare the efficacy of these modalities. This head-to-head randomized study included sixty patients diagnosed with primary knee osteoarthritis (OA) according to the American College of Rheumatology (ACR) criteria and radiologically evaluated as Kellgren-Lawrence stages 2 and 3 bilateral OA patients were divided into two groups according to the therapy: high-intensity laser (HILT) with exercise (n = 30) and short-wave diathermy (SWD) with exercise (n = 30) in which patients treated for 2 weeks (5 days a week for a total of 10 sessions). Visual Analogue Scale (VAS), The Western Ontario and McMaster Universities Arthritis Index (WOMAC), Timed Up and Go, Stair Climb, 30-s chair-stand, 40-meter Fast-paced Walk, and Short Form Survey (SF-36) tests were performed before and after treatments. Compared to pretreatment, HILT + exercise therapy improved all the test results, while SWD + exercise therapy also improved test scores except for the 30-s chair-stand and 40-meter Fast-paced Walk tests. When HILT + exercise therapy was compared with SWD + exercise therapy, HILT treatment was more effective in all tests except the Stair Climb and 40-meter Fast-paced Walk tests. Although the treatments applied with exercise were effective in both groups, HILT was more effective than SWD in terms of pain, physical, functional, and quality of life. HILT was recommended in the treatment plan of patients with stage 2–3 knee osteoarthritis.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.